Improving Biopharmaceutical Technician Education with Cell and Gene Therapy Credentials
利用细胞和基因治疗证书改善生物制药技术人员教育
基本信息
- 批准号:2155187
- 负责人:
- 金额:$ 35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Over the past four years more than 30 cell and gene therapy companies have started or become located in Montgomery County, Maryland, making it an emerging center for biopharmaceutical industries. Montgomery College will address the critical workforce needs of this growing industry by increasing the number of work-ready biotechnicians with a focus on cell and gene therapy. The biotechnology program at Montgomery College will add a new Certificate in Cell and Gene therapy with an expected annual enrollment of 20 students by 2025. They will combine this new certificate program with two new micro-credentials in Micropipetting and Aseptic Techniques for Mammalian Cell Culture. Skills from these courses and credentials will be vetted by industry professionals to ensure alignment with their expectations for entry-level biotechnology positions. Finally, the college plans to increase awareness and enrollment in the biotechnology program through increased outreach combined with a comprehensive marketing strategy, and focus group analysis.Montgomery College plans to improve educational outcomes for students in the biotechnology program by creating a new Principles of Cell and Gene Therapy Technology course that will be part of the new Cell and Gene Therapy certificate. The certificate will include three existing courses that feature a strong regulatory component that addresses the essential elements of FDA compliance for therapeutics. The college will consult with an industry advisory group to develop new micro credentials in Micropipetting and Aseptic Techniques for Mammalian Cell Culture. While these are considered standard techniques, Montgomery College plans to achieve industrial buy-in for these credentials which can augment degrees and certificates and improve employment opportunities for students. To improve enrollment in the program, the college will conduct focus groups to determine baseline data regarding student interest and knowledge of biotechnology careers. They will also develop a 10-hour biotechnology camp for Montgomery County students and educators to improve the program’s outreach. A program evaluator will monitor the progress of the project and will use formative and summative assessments to guide it. This project is funded by the Advanced Technological Education program that focuses on the education of technicians for the advanced-technology fields that drive the nation's economy.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
在过去的四年里,超过30家细胞和基因治疗公司在马里兰州蒙哥马利县成立或落户,使其成为新兴的生物制药工业中心。蒙哥马利学院将通过增加工作就绪的生物技术人员的数量,专注于细胞和基因治疗,来解决这个不断发展的行业的关键劳动力需求。蒙哥马利学院的生物技术项目将增加一个新的细胞和基因治疗证书,预计到2025年每年招收20名学生。他们将把这个新的证书课程与两个新的微证书相结合,分别是微移液和哺乳动物细胞培养无菌技术。这些课程的技能和证书将由行业专业人士审查,以确保符合他们对入门级生物技术职位的期望。最后,学院计划通过扩大宣传,结合全面的营销策略和焦点小组分析,提高生物技术项目的知名度和入学率。蒙哥马利学院计划通过开设一门新的细胞和基因治疗技术原理课程来提高生物技术专业学生的教育成果,这门课程将成为新的细胞和基因治疗证书的一部分。该证书将包括三个现有课程,具有强大的监管成分,解决治疗药物符合FDA的基本要素。该学院将与一个行业咨询小组协商,开发新的微证书,用于哺乳动物细胞培养的微移液和无菌技术。虽然这些被认为是标准技术,但蒙哥马利学院计划实现这些证书的工业购买,这些证书可以增加学位和证书,并改善学生的就业机会。为了提高该计划的入学率,学院将进行焦点小组讨论,以确定有关学生对生物技术职业的兴趣和知识的基线数据。他们还将为蒙哥马利县的学生和教育工作者开设一个10小时的生物技术夏令营,以提高项目的推广效果。计划评估员将监视项目的进展,并使用形成性和总结性评估来指导它。该项目由先进技术教育计划资助,该计划侧重于为推动国家经济的先进技术领域培养技术人员。该奖项反映了美国国家科学基金会的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Collins Jones其他文献
In Vivo Imaging of Fatty Acid Incorporation into Brain to Examine Signal Transduction and Neuroplasticity Involving Phospholipids
脂肪酸掺入大脑的体内成像,以检查涉及磷脂的信号转导和神经可塑性
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:5.2
- 作者:
S. Rapoport;D. Purdon;H. Shetty;E. Grange;Q. Smith;Collins Jones;Michael C. J. Chang - 通讯作者:
Michael C. J. Chang
Collins Jones的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
抗菌药物耐药性生物制药产品开发的临床前服务
- 批准号:
10934774 - 财政年份:2023
- 资助金额:
$ 35万 - 项目类别:
Preclinical Services for Biopharmaceutical Product Development
生物制药产品开发的临床前服务
- 批准号:
10934767 - 财政年份:2023
- 资助金额:
$ 35万 - 项目类别:
Preclinical Services for Biopharmaceutical Product Development
生物制药产品开发的临床前服务
- 批准号:
10934723 - 财政年份:2023
- 资助金额:
$ 35万 - 项目类别:
Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
抗菌药物耐药性生物制药产品开发的临床前服务
- 批准号:
10934772 - 财政年份:2023
- 资助金额:
$ 35万 - 项目类别:
Preclinical Services for Biopharmaceutical Product Development
生物制药产品开发的临床前服务
- 批准号:
10934778 - 财政年份:2023
- 资助金额:
$ 35万 - 项目类别:
Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
抗菌药物耐药性生物制药产品开发的临床前服务
- 批准号:
10934750 - 财政年份:2023
- 资助金额:
$ 35万 - 项目类别:
Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
抗菌药物耐药性生物制药产品开发的临床前服务
- 批准号:
10934793 - 财政年份:2023
- 资助金额:
$ 35万 - 项目类别:
Preclinical Services for Biopharmaceutical Product Development
生物制药产品开发的临床前服务
- 批准号:
10934794 - 财政年份:2023
- 资助金额:
$ 35万 - 项目类别:
NSF Engines Development Award: Advancing biopharmaceutical technologies and manufacturing practices (PR)
NSF 引擎开发奖:推进生物制药技术和制造实践 (PR)
- 批准号:
2305699 - 财政年份:2023
- 资助金额:
$ 35万 - 项目类别:
Cooperative Agreement
Preclinical Services for Biopharmaceutical Product Development
生物制药产品开发的临床前服务
- 批准号:
10934773 - 财政年份:2023
- 资助金额:
$ 35万 - 项目类别: